secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvalent, Inc. (NUVL)
CIK:        0001861560
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0001564590-22-033704
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Nuvalent elects Dr. Michael L. Meyers to the Board as Class II director
-----------------------------------------------------------------------

- Dr. Meyers was elected independent Class II director effective October 4, 2022.
- He will also serve on the Nominating and Corporate Governance Committee.
- Received initial option grant for 40,000 shares at $19.48 per share, vesting monthly over 3 years.
- Compensation follows Nuvalent's non-employee director policy including annual cash retainers and equity.
- No family relationships or transactions with the Company requiring disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/0001564590-22-033704-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/nuvl-8k_20221004.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-033704

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer